Welcome to all of our witnesses this evening, and to those joining us online.
My name is Yonah Martin, and I am the Senate's joint chair of this committee. I am joined by Shelby Kramp-Neuman, the House of Commons vice-chair of the committee.
Today, we continue our examination of the degree of preparedness attained for a safe and adequate application of medical assistance in dying where mental disorder is the sole underlying medical condition, in accordance with recommendation 13 of the committee's second report.
Before I introduce our witnesses, I want to advise our House colleagues that, potentially, there could be votes in the Senate in the second hour, so we'll be called away, at which point we will suspend the committee meeting. We don't know just yet what will happen, but it would be in the second hour.
For our first panel this evening, we have H. Archibald Kaiser, professor at the Schulich School of Law and department of psychiatry at Dalhousie University's faculty of medicine, as an individual, by video conference; Dr. Tarek Rajji, chair of the medical advisory committee at the Centre for Addiction and Mental Health; Dr. Mauril Gaudreault, president of Collège des médecins du Québec; and Dr. André Luyet, psychiatrist, both by video conference.
Welcome to our witnesses for this first panel. You will each have five minutes for your opening remarks. We trust that you will be within the five minutes.
We will begin with Professor Kaiser, followed by Dr. Rajji and Dr. Gaudreault. I'm not sure if Dr. Luyet is sharing the five minutes, or whether it will just be Dr. Gaudreault.
We'll begin with Professor Kaiser. You have five minutes.